Clinical Evidence# Afamelanotide Clinical Trials# Multiple Phase 2 and Phase 3 trials have evaluated afamelanotide: EPP Phase 3 (CUV039) : Randomized, double-blind, placebo-controlled trial in 93 EPP patients
O nosso compromisso com a transparncia inclui a publicao dos resultados dos ensaios, a verificao da pureza, a confirmao da identidade, os testes de endotoxinas, o rastreio microbiano e a anlise de impurezas elementares
2021;277:121110 Dolma S, Lessnick SL, Hahn WC, Stockwell BR
Evidence from preclinical models suggests that the peptide may influence immune-mediated pathways involved in swelling, tissue damage, and repair
Fisher WE, Boros LG, Schirmer WJ
Sulforaphane regulates phenotypic and functional switching of both induced and spontaneously differentiating human monocytes